Sort
30,917 grants matching “tumor microenvironment”
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$455,145Marcus E Peter · Northwestern University At Chicago · R01 · FY2024 · CA
Secretable theranostic payloads to augment the efficacy of adoptive CAR-T cell therapies
$455,112Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R21 · FY2020 · CA
TGF-beta Suppression and Promotion of Mammary Carcinomas
$455,112Harold L Moses · Vanderbilt University · R01 · FY2015 · CA
Downstream of Akt in the tumor vessel
$455,087William C Aird · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
Metabolic checkpoint in dendritic cell subsets and adaptive immunity
$455,000Hongbo Chi · St. Jude Children'S Research Hospital · R37 · FY2024 · AI
Metabolic checkpoint in dendritic cell subsets and adaptive immunity
$455,000Hongbo Chi · St. Jude Children'S Research Hospital · R37 · FY2025 · AI
A democratized platform for mapping the spatial epigenome in tissue
$454,975Jeffrey Sabina · Atlasxomics Inc. · R44 · FY2024 · CA
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems
$454,956Manish Aghi · University Of California, San Francisco · R01 · FY2018 · CA
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity
$454,933Viswanathan Palanisamy · Medical University Of South Carolina · R01 · FY2021 · DE
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity
$454,933Viswanathan Palanisamy · Medical University Of South Carolina · R01 · FY2020 · DE
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$454,876Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
$454,817Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2017 · CA
Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma
$454,799Jesus Delgado-Calle · Univ Of Arkansas For Med Scis · R01 · FY2025 · CA
Administrative Core
$454,764Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
Environmental Effect on the Mammary Gland across the Lifespan
$454,762Zena Werb · University Of California, San Francisco · U01 · FY2013 · ES
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
$454,731Albert Hong-Jae Kim · Washington University · R01 · FY2021 · NS
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$454,727Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · DK
Development of Novel Metal-Based Supramolecular Therapeutics for Ovarian Cancer
$454,646Yaorong Zheng · Kent State University · R15 · FY2021 · CA
TGF-Beta Suppression and Promotion of Mammary Carcinomas
$454,641Harold L Moses · Vanderbilt University · R01 · FY2009 · CA
Induction of Tumor Immunity by Secreted HSP-gp96
$454,604Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2010 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$454,539Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
A Systems Biology Approach to Investigate the Structure Changes of Biological Network
$454,500Haijun Gong · Saint Louis University · R15 · FY2018 · GM
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$454,472Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2023 · CA
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$454,467Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2022 · CA
Core D: Pathology and BioImaging
$454,463Carl D Morrison · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA